Clinical Trial Update: A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing pregabalin for nerve pain due to spinal cord injury has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuralgia
• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuralgia, Spinal Cord Injuries | Phase 3 | Status: COMPLETED | Results posted: 2011-12-08